DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-3.27%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.01B
AUM Growth
+$262M
(+4.6%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159
Top Buys
| 1 |
WAY
Waystar Holding Corp
WAY
|
$106M |
| 2 |
Gilead Sciences
GILD
|
$102M |
| 3 |
CVS Health
CVS
|
$57.6M |
| 4 |
Baxter International
BAX
|
$52.6M |
| 5 |
Cullinan Oncology
CGEM
|
$37.4M |
Top Sells
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$136M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$80.7M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$63.2M |
| 4 |
Oscar Health
OSCR
|
$38.2M |
| 5 |
Viking Therapeutics
VKTX
|
$38M |
Sector Composition
| 1 | Healthcare | 83.29% |
| 2 | Industrials | 0.67% |
| 3 | Technology | 0.57% |
| 4 | Financials | 0.44% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Sutro Biopharma
STRO
$81.5M
| – | – |
-16,925
| Closed | -$95.6K |
|
577
State Street
STT
$32.2B
| – | – |
-3,967
| Closed | -$307K |
|
578
Supernus Pharmaceuticals
SUPN
$2.54B
| – | – |
-6,654
| Closed | -$227K |
|
579
Skyworks Solutions
SWKS
$10.8B
| – | – |
-5,407
| Closed | -$586K |
|
|
SWTX
580
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-1,283,176
| Closed | -$63.2M |
|
581
Stock Yards Bancorp
SYBT
$2.34B
| – | – |
-9,821
| Closed | -$480K |
|
582
AT&T
T
$211B
| – | – |
-19,441
| Closed | -$342K |
|
583
Terns Pharmaceuticals
TERN
$657M
| – | – |
-24,060
| Closed | -$158K |
|
584
Gentherm
THRM
$1.09B
| – | – |
-5,557
| Closed | -$320K |
|
585
Tiptree Inc
TIPT
$870M
| – | – |
-16,728
| Closed | -$289K |
|